1. Home
  2. KROS vs VREX Comparison

KROS vs VREX Comparison

Compare KROS & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KROS
  • VREX
  • Stock Information
  • Founded
  • KROS 2015
  • VREX 2016
  • Country
  • KROS United States
  • VREX United States
  • Employees
  • KROS N/A
  • VREX N/A
  • Industry
  • KROS Biotechnology: Pharmaceutical Preparations
  • VREX Industrial Machinery/Components
  • Sector
  • KROS Health Care
  • VREX Technology
  • Exchange
  • KROS Nasdaq
  • VREX Nasdaq
  • Market Cap
  • KROS 589.8M
  • VREX 582.3M
  • IPO Year
  • KROS 2020
  • VREX N/A
  • Fundamental
  • Price
  • KROS $11.39
  • VREX $13.88
  • Analyst Decision
  • KROS Buy
  • VREX Strong Buy
  • Analyst Count
  • KROS 11
  • VREX 1
  • Target Price
  • KROS $45.33
  • VREX $21.00
  • AVG Volume (30 Days)
  • KROS 1.9M
  • VREX 427.7K
  • Earning Date
  • KROS 02-26-2025
  • VREX 02-04-2025
  • Dividend Yield
  • KROS N/A
  • VREX N/A
  • EPS Growth
  • KROS N/A
  • VREX N/A
  • EPS
  • KROS N/A
  • VREX N/A
  • Revenue
  • KROS $651,000.00
  • VREX $811,000,000.00
  • Revenue This Year
  • KROS $303.27
  • VREX $3.50
  • Revenue Next Year
  • KROS N/A
  • VREX $3.37
  • P/E Ratio
  • KROS N/A
  • VREX N/A
  • Revenue Growth
  • KROS 8037.50
  • VREX N/A
  • 52 Week Low
  • KROS $9.78
  • VREX $10.19
  • 52 Week High
  • KROS $73.00
  • VREX $20.08
  • Technical
  • Relative Strength Index (RSI)
  • KROS 22.41
  • VREX 44.16
  • Support Level
  • KROS $9.78
  • VREX $13.47
  • Resistance Level
  • KROS $11.63
  • VREX $14.05
  • Average True Range (ATR)
  • KROS 0.86
  • VREX 0.40
  • MACD
  • KROS 1.15
  • VREX -0.01
  • Stochastic Oscillator
  • KROS 23.32
  • VREX 36.71

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

About VREX Varex Imaging Corporation

Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital flat panel image detectors, high voltage connectors, ionization chambers, and buckys among others. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors and high voltage connectors among others. It has manufacturing, research, and development operation in the United States, Europe, Philippines and China, and sales and service operations throughout the world.

Share on Social Networks: